A phase IIa study of ABT-263 in patients with relapsed small-cell lung cancer (SCLC). Background: To compare the presenting and prognostic characteristics, cause-specific survival (CSS) rates, and ...

BioNTech SE(Nasdaq: BNTX, "BioNTech" or "the Company") will present clinical trial data from select pipeline candidates across the Company's diversified oncology portfolio ...

16 Wes Anderson Movies (The Phoenician Scheme), Ranked by Tomatometer Link to 16 Wes Anderson Movies (The Phoenician Scheme), Ranked by Tomatometer 100 Best Movies of 1985 (The Goonies), Ranked by ...

Zai Lab Limited gains momentum with FDA Fast Track nod and solid earnings, signaling growth potential. Click here to find out why ZLAB stock is a Buy.

He is currently an Associate Professor at the Department of Chemical and Biological Engineering, heading the SCLC group. He also holds the highly prestigious Australian Research Council Future ...

Real-world data show first-line chemo-immunotherapy improves survival and response rates over chemo alone in extensive-stage SCLC, supporting its broader use. A recent retrospective study evaluated ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following investor conferences: Jefferies Global ...

This symbol replaces the prior symbol of "DMN" under which the Company previously traded. This change comes as Damon continues to build momentum, highlighted by its innovative product offerings ...

The agent is currently being evaluated as both monotherapy and in combination with atezolizumab in patients with extensive stage SCLC in an ongoing, global phase 1 trial. The FDA granted fast track ...

The Company is on track to initiate a pivotal study for ZL-1310 in small cell lung cancer (SCLC) in 2025 SHANGHAI & CAMBRIDGE, Mass., May 19, 2025--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. But woven throughout ...